GOLDENWELL BIOTECH, INC. (GWLL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20K 40K 60K Q3 '21: 13.3K Q4 '21: 18.2K Q1 '22: 18.6K Q2 '22: 21.2K Q3 '22: 52.7K Q4 '22: 47.8K Q1 '23: 48.8K Q2 '23: 45.4K Q3 '23: 2.1K Q4 '23: 2.3K Q1 '24: 918 Q2 '24: 781 Q3 '24: 399 Q4 '24: 139 Q1 '25: 139 Q2 '25: 0 Q3 '25: 0 Q4 '25: 55 Q1 '26: 55 Q2 '26: 55 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 10K 20K 30K Q3 '21: 7K Q4 '21: 9.6K Q1 '22: 9.8K Q2 '22: 11.1K Q3 '22: 27.8K Q4 '22: 25.2K Q1 '23: 25.7K Q2 '23: 23.9K Q3 '23: 1K Q4 '23: 1.1K Q1 '24: 397 Q2 '24: 329 Q3 '24: 143 Q4 '24: 70 Q1 '25: 70 Q2 '25: 0 Q3 '25: 0 Q4 '25: 12 Q1 '26: 12 Q2 '26: 12 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-1.1M -700K -350K 0 350K 700K 1.1M Q2 '22: -249.2K Q3 '22: -165K Q4 '22: -985.1K Q1 '23: -985.3K Q2 '23: -985.6K Q3 '23: -1M Q4 '23: -116.9K Q1 '24: -112.2K Q2 '24: -133K Q3 '24: -118.5K Q4 '24: -123.1K Q1 '25: -130.6K Q2 '25: -111K Q3 '25: -115.8K Q4 '25: -113.3K Q1 '26: -108.2K Q2 '26: -114.8K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-1.1M -700K -350K 0 350K 700K 1.1M Q3 '21: -160.1K Q4 '21: -186.7K Q1 '22: -173.9K Q2 '22: -177.2K Q3 '22: -94.3K Q4 '22: -985.1K Q1 '23: -985.3K Q2 '23: -985.6K Q3 '23: -1M Q4 '23: -116.9K Q1 '24: -114.3K Q2 '24: -137.1K Q3 '24: -124.8K Q4 '24: -131.4K Q1 '25: -139K Q2 '25: -119.4K Q3 '25: -124.2K Q4 '25: -296.5K Q1 '26: -275.5K Q2 '26: -282.1K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 9K 18K 27K Q3 '21: 6.3K Q4 '21: 8.6K Q1 '22: 8.8K Q2 '22: 10.1K Q3 '22: 24.9K Q4 '22: 22.6K Q1 '23: 23.1K Q2 '23: 21.5K Q3 '23: 1K Q4 '23: 1.2K Q1 '24: 521 Q2 '24: 452 Q3 '24: 256 Q4 '24: 69 Q1 '25: 69 Q2 '25: 0 Q3 '25: 0 Q4 '25: 43 Q1 '26: 43 Q2 '26: 43 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-1.2M -800K -400K 0 400K 800K 1.2M Q3 '21: -315.9K Q4 '21: -332.3K Q1 '22: -327.7K Q2 '22: -202.6K Q3 '22: -174.8K Q4 '22: -1.1M Q1 '23: -958.8K Q2 '23: -960.7K Q3 '23: -1M Q4 '23: -113.2K Q1 '24: -110.2K Q2 '24: -131K Q3 '24: -116.8K Q4 '24: -123.1K Q1 '25: -126.3K Q2 '25: -19.2K Q3 '25: -29.1K Q4 '25: -22.6K Q1 '26: -3.7K Q2 '26: -110.4K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '22: 91.3M Q2 '23: 96.4M Q1 '24: 99M Q2 '24: 96.4M Q3 '24: 96.4M Q4 '24: 99M Q1 '25: 99M Q2 '25: 99M Q3 '25: 96.4M Q4 '25: 99M Q1 '26: 99M Q2 '26: 99M Q2 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '20 Q4 '20 Q2 '21 Q4 '21 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.